A carregar...
“Repurposing FDA Approved Drugs Inhibiting Mitochondrial Function for Targeting Glioma-Stem Like Cells.”
Glioblastoma Multiforme (GBM) tumors contain a small population of glioma stem-like cells (GSCs) among the various differentiated GBM cells (d-GCs). GSCs drive tumor recurrence, and resistance to Temozolomide (TMZ), the standard of care (SoC) for GBM chemotherapy. In order to investigate a potential...
Na minha lista:
| Publicado no: | Biomed Pharmacother |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8092590/ https://ncbi.nlm.nih.gov/pubmed/33378970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopha.2020.111058 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|